Mary Beth Beasley Selected Research

Mary Beth Beasley Research Topics

Disease

21	Neoplasms (Cancer) 12/2021 - 02/2003
12	Adenocarcinoma 01/2019 - 01/2011
11	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2011
8	Carcinoma (Carcinomatosis) 03/2018 - 02/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 05/2011
4	Mesothelioma 01/2020 - 05/2013
3	Malignant Mesothelioma 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2018 - 01/2014
2	Lung Diseases (Lung Disease) 01/2018 - 09/2002
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2018 - 10/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 05/2013
2	Lung Injury 12/2017 - 01/2014
2	Carcinoid Tumor (Carcinoid) 07/2013 - 02/2003
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2013 - 02/2003
1	Testicular Neoplasms (Testicular Cancer) 12/2021
1	COVID-19 01/2021
1	Lymphocytosis 01/2018
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2017
1	Adenocarcinoma of Lung 01/2017
1	Circulating Neoplastic Cells 08/2016
1	Sarcoma (Soft Tissue Sarcoma) 03/2016
1	Small Cell Carcinoma 07/2013
1	Leukemia 07/2013
1	Neoplasm Metastasis (Metastasis) 11/2012
1	Cushing Syndrome 11/2012
1	Hyperandrogenism 11/2012
1	Adrenocortical Carcinoma 11/2012
1	Pneumoconiosis 02/2007
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2007
1	Hamartoma 03/2003
1	Pneumonia (Pneumonitis) 03/2003
1	Disease Progression 09/2002
1	Vascular Diseases (Vascular Disease) 09/2002
1	Lymphoma (Lymphomas) 09/2002
1	Human Influenza (Influenza) 09/2002
1	Organizing Pneumonia 09/2002

Drug/Important Bio-Agent (IBA)

7	Tyrosine Kinase InhibitorsIBA 03/2018 - 05/2011
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2016
5	ErbB Receptors (EGF Receptor)IBA 07/2013 - 07/2007
4	AntibodiesIBA 01/2020 - 05/2013
4	Cell-Free Nucleic AcidsIBA 03/2018 - 08/2016
4	Anaplastic Lymphoma KinaseIBA 03/2016 - 06/2013
3	AntigensIBA 12/2021 - 10/2013
3	B7-H1 AntigenIBA 01/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2013
2	CytokinesIBA 01/2021 - 01/2014
2	Immune Checkpoint InhibitorsIBA 01/2021 - 04/2016
2	Biological ProductsIBA 12/2019 - 12/2017
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2016 - 10/2008
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020
1	Inosine Monophosphate (IMP)IBA 01/2020
1	Keratins (Keratin)IBA 01/2020
1	complement 1q receptorIBA 01/2019
1	Thyroid Nuclear Factor 1IBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2018
1	MucinsIBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	xylometazoline (stas)IBA 06/2016
1	LigandsIBA 04/2016
1	Epidermal Growth Factor (EGF)IBA 03/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014
1	cadmium oxideIBA 01/2014
1	Histones (Histone)IBA 07/2013
1	Coloring Agents (Dyes)IBA 07/2013
1	Transcription Factors (Transcription Factor)IBA 07/2013
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2012
1	EnzymesIBA 11/2012
1	dehydroepiandrosterone sulfotransferaseIBA 11/2012
1	Dehydroepiandrosterone (DHEA)IBA 11/2012
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2012
1	Etoposide (VP 16)FDA LinkGeneric 10/2008
1	Cisplatin (Platino)FDA LinkGeneric 10/2008
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 10/2008
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2008
1	hard metalIBA 02/2007
1	Cyclin D1IBA 02/2003
1	Retinoblastoma ProteinIBA 02/2003
1	CollagenIBA 09/2002
1	Amiodarone (Amiodarona)FDA LinkGeneric 09/2002
1	FibrinIBA 09/2002

Therapy/Procedure

10	Therapeutics 01/2021 - 07/2007
4	Immunotherapy 12/2021 - 04/2016
3	Drug Therapy (Chemotherapy) 01/2020 - 05/2011
1	Pneumonectomy (Lung Volume Reduction) 01/2020
1	Segmental Mastectomy (Lumpectomy) 07/2014
1	Molecular Targeted Therapy 01/2011
1	Debridement 03/2003
1	Lasers (Laser) 03/2003
1	Artificial Respiration (Mechanical Ventilation) 09/2002